Evidence map›Paper›PMID 22593769›Full record

ReviewClinical & developmental immunology2012

Recurrent herpetic stromal keratitis in mice: a model for studying human HSK.

Patrick M Stuart, Tammie L Keadle

Open access · goldAbstract readReview
In one paragraph

Review in Clinical & developmental immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Role of IL-27 in HSV-1-Induced Herpetic Stromal Keratitis.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Article
  7. Review
  8. Article
  9. Upregulation of Multiple CD8Journal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Bolstering the Number and Function of HSV-1-Specific CD8Journal of immunology (Baltimore, Md. : 1950) · 2017
    Article
  15. Article
  16. Innate Immune Mechanisms and Herpes Simplex Virus Infection and Disease.Advances in anatomy, embryology, and cell biology · 2017
    Review
  17. IL-2 complex treatment amplifies CD8Microbes and infection · 2016
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Patrick M StuartDepartment of Ophthalmology, Saint Louis University School of Medicine, St. Louis, MO 63104-1004, USA. pstuart2@slu.edu
Tammie L Keadle
Saint Louis University · USWashington University in St. Louis · US

Funding

AMELIORATION OF RECURRENT HERPES KERATITISR01EY011885 · NEI · WASHINGTON UNIVERSITY · PI STUART, PATRICK M · 1998 to 2007
$2.3M
Mechanisms of HSK ameliorationR01EY021247 · NEI · SAINT LOUIS UNIVERSITY · PI STUART, PATRICK M · 2011 to 2014
$1.4M
THE ROLE OF APOPTOTIC MOLECULES IN HERPETIC STROMALR01EY016352 · NEI · SAINT LOUIS UNIVERSITY · PI STUART, PATRICK M · 2009 to 2010
$697k
NEI NIH HHS EY11885NEI NIH HHS EY16352NEI NIH HHS EY21247NEI NIH HHS R01 EY011885NEI NIH HHS R01 EY016352NEI NIH HHS R01 EY021247
6 · The paper itself

Abstract

Herpes simplex virus 1 (HSV-1) infection of the cornea leads to a potentially blinding disease, termed herpetic stromal keratitis (HSK) that is characterized by lesions of an immunoinflammatory nature. In spite of the fact that HSK typically presents as a recurrent disease due to reactivation of virus which latently infects the trigeminal ganglia, most murine studies of HSK have employed a primary and not recurrent model of the disease. This report documents the several recurrent models of HSK that have been developed and how data generated from these models differs in some important aspects from data generated following primary infection of the cornea. Chief among these differences is the fact that recurrent HSK takes place in the context of an animal that has a preexisting anti-HSV immune response, while primary HSK occurs in an animal that is developing such a response. We will document both differences and similarities that derive from this fundamental difference in these models with an eye towards possible vaccines and therapies that demonstrate promise in treating HSK.

Indexed as

AnimalsCorneaDisease Models, AnimalHerpes SimplexHerpesvirus 1, HumanHumansImmunologic MemoryKeratitis, HerpeticMiceRecurrenceTrigeminal GanglionVirus Activation

Identifiers

PMID22593769
PMCPMC3347728
OpenAlexW2056712418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.